Amlogenyx
Latest round
- Seed
Last raised
- Jul 2024
Total raised
- $14M
Investors
- 2
About Amlogenyx
Founded in 2023 and based in California, US, Amlogenyx Inc. operates as a novel gene therapeutics company. In July 2024, Amlogenyx Inc.49 million post-money. Amlogenyx develops novel gene therapies for Alzheimer’s disease and other amyloid diseases. The company’s lead product candidate is a protease (an enzyme that breaks down proteins) developed in collaboration with St. Jude Children's Research Hospital. The enzyme breaks down and degrades Aß42, a protein widely believed to be a key factor in the development of Alzheimer's disease.
Who invested in Amlogenyx
2 investors across 1 round
See all investors in Amlogenyx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 26, 2024
Amount
$14M
Investors
Questions about Amlogenyx
Who invested in Amlogenyx?
Amlogenyx has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amlogenyx raised?
Amlogenyx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amlogenyx last raise money?
Amlogenyx's most recent round on record is a Seed, in Jul 2024.
What does Amlogenyx do?
Founded in 2023 and based in California, US, Amlogenyx Inc.
Where is Amlogenyx headquartered?
Amlogenyx is headquartered in Novato, US.
Which VCs invest in companies like Amlogenyx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amlogenyx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Amlogenyx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.